Featured Research

from universities, journals, and other organizations

Delayed-release Stimulant Used To Treat ADHD May Be Less Subject To Abuse

Date:
March 2, 2006
Source:
Massachusetts General Hospital
Summary:
A team led by Massachusetts General Hospital researchers has found that a delayed-release stimulant used to treat attention-deficit hyperactivity disorder may be less likely to be abused than other stimulant drugs.

A team led by Massachusetts General Hospital (MGH) researchers has found that a delayed-release stimulant used to treat attention-deficit hyperactivity disorder (ADHD) may be less likely to be abused than other stimulant drugs. Study participants taking therapeutic oral doses of Concerta, a once-daily form of the drug methylphenidate, did not report perceiving and enjoying the drug's subjective effects, features that are associated with a medication's potential for abuse. The report appears in the March 2006 issue of The American Journal of Psychiatry.

Related Articles


"We know that drugs that cause euphoria are potentially abusable, and euphoria requires rapid delivery to the brain. Using sophisticated PET scan imaging, we were able to examine the rate of delivery of both rapid- and delayed-release formulations of methylphenidate and correlate those results with how the drugs felt to study volunteers," says Thomas Spencer, MD, of the MGH Pediatric Psychopharmacology Unit, the paper's lead author. "The ability to show that rate of brain delivery may determine abuse potential is important to our understanding of the safety of different formulations."

Methylphenidate and other stimulant drugs used to treat ADHD act by blocking the dopamine transporter, a molecule on brain cells that takes up the neurotransmitter dopamine, raising its level in the brain. Studies have shown that the brains of ADHD patients have abnormal regulation of dopamine, which plays a key role in the control of movement, behavior and attention. While stimulants are effective for controlling ADHD symptoms, the drugs are also subject to abuse, so the current study was designed to compare the abuse potential of two formulations of methylphenidate.

The researchers compared a traditional, quick-release form of the drug with Concerta, a formulation that is released over 12 hours to produce a gradual increase in blood levels. With Concerta, the drug passes slowly through a hole in capsules that do not dissolve, reducing the possibility that the gradual-release feature might be bypassed. Study participants received the two medications at dosages designed to produce comparable peak levels in the blood and brain.

Twelve adult volunteers, none diagnosed with ADHD or any neurological or psychiatric disorder, were randomly assigned to receive either the immediate-release or delayed-release form of methylphenidate on two separate days. PET scans -- which showed whether or not the dopamine transporter molecule was occupied by the medication -- were taken the day before drug administration as a baseline, one and three hours after the first drug administration and five and seven hours after a second drug administration on a different day. During the 10 hours after each drug administration, hourly blood samples were taken from the volunteers, who also completed hourly questionnaires regarding whether they were aware of the drug's effects and whether they enjoyed or disliked those effects.

As expected, the delayed-release formulation took longer to produce maximum blood levels and blockade of the dopamine transporter than did the immediate-release drug. While most of those receiving immediate-release methylphenidate reported detecting and enjoying the drug's activity, few of those receiving the delayed-release form were aware of or enjoyed the drug's effects.

"The differing reports on feeling and liking the drug effects occurred despite using larger doses of the delayed-release formulation and the equivalent peak blood and brain levels," says Spencer. "Previous studies have showed that both versions are effective for treating ADHD. Whether delayed- or sustained-release formulations of other potentially abusable ADHD drugs share the same safety characteristics needs be studied, since different forms vary in the levels and timing of drug delivery." Spencer is an associate professor of Psychiatry at Harvard Medical School.

###

The study was supported by grants from the National Institute of Mental Health and McNeil Consumer & Specialty Pharmaceuticals, which manufactures Concerta. The study's co-authors are Joseph Biederman, MD, Bertha Madras, PhD, and Darin Dougherty, MD, of MGH Psychiatry; Ali Bonab, PhD, Elijahu Livni, PhD, and Alan Fischman, MD, PhD, of MGH Radiology; and Patrick Ciccone, MD, and Dolly Parasrampuria, PhD, of McNeil.


Story Source:

The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts General Hospital. "Delayed-release Stimulant Used To Treat ADHD May Be Less Subject To Abuse." ScienceDaily. ScienceDaily, 2 March 2006. <www.sciencedaily.com/releases/2006/03/060301092848.htm>.
Massachusetts General Hospital. (2006, March 2). Delayed-release Stimulant Used To Treat ADHD May Be Less Subject To Abuse. ScienceDaily. Retrieved December 21, 2014 from www.sciencedaily.com/releases/2006/03/060301092848.htm
Massachusetts General Hospital. "Delayed-release Stimulant Used To Treat ADHD May Be Less Subject To Abuse." ScienceDaily. www.sciencedaily.com/releases/2006/03/060301092848.htm (accessed December 21, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, December 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
The Best Protein-Filled Foods to Energize You for the New Year

The Best Protein-Filled Foods to Energize You for the New Year

Buzz60 (Dec. 19, 2014) The new year is coming and nothing will energize you more for 2015 than protein-filled foods. Fitness and nutrition expert John Basedow (@JohnBasedow) gives his favorite high protein foods that will help you build muscle, lose fat and have endless energy. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins